UBS Maintains Buy on Acadia Healthcare Co, Raises Price Target to $31

Benzinga Newsdesk www.benzinga.com Positive 86.0%

Neg 0% Neu 0% Pos 86%

UBS analyst A.J. Rice maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and raises the price target from $27 to $31.